Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Igor Vujic

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
JAAD International|August 19, 2021
Effectiveness and clinical predictors of drug survival in psoriasis patients receiving apremilast: A registry analysisThomas Graier, Wolfgang Weger, Paul-Gunther Sator, et al.
Molecular Cancer|February 21, 2024
The therapeutically actionable long non-coding RNA 'T-RECS' is essential to cancer cells' survival in NRAS/MAPK-driven melanomaValentin Feichtenschlager, Linan Chen, Yixuan James Zheng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 27, 2022
Novel Lymphocyte-Independent Antitumor Activity by PD-1 Blocking Antibody against PD-1+ Chemoresistant Lung Cancer CellsRamona Rotolo, Valeria Leuci, Chiara Donini, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|October 31, 2023
Evolution of characteristics and biologic treatment effectiveness in patients of the Austrian psoriasis registry from 2004-2022Thomas Graier, Wolfgang Salmhofer, Constanze Jonak, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|December 12, 2023
Entwicklung der Patientencharakteristika und der Wirksamkeit der Biologika-Therapie bei Patienten des Österreichischen Psoriasis-Registers von 2004 bis 2022Thomas Graier, Wolfgang Salmhofer, Constanze Jonak, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 25, 2023
S2k guidelines on the management of paraneoplastic pemphigus/paraneoplastic autoimmune multiorgan syndrome initiated by the European Academy of Dermatology and Venereology (EADV)Emiliano Antiga, Rikke Bech, Roberto Maglie, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 13, 2023
Corrigendum: S2k guidelines on the management of paraneoplastic pemphigus/paraneoplastic autoimmune multiorgan syndrome initiated by the European Academy of Dermatology and Venereology (EADV)Emiliano Antiga, Rikke Bech, Roberto Maglie, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
JAAD International|August 19, 2021
Effectiveness and clinical predictors of drug survival in psoriasis patients receiving apremilast: A registry analysisThomas Graier, Wolfgang Weger, Paul-Gunther Sator, et al.
Molecular Cancer|February 21, 2024
The therapeutically actionable long non-coding RNA 'T-RECS' is essential to cancer cells' survival in NRAS/MAPK-driven melanomaValentin Feichtenschlager, Linan Chen, Yixuan James Zheng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 27, 2022
Novel Lymphocyte-Independent Antitumor Activity by PD-1 Blocking Antibody against PD-1+ Chemoresistant Lung Cancer CellsRamona Rotolo, Valeria Leuci, Chiara Donini, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|October 31, 2023
Evolution of characteristics and biologic treatment effectiveness in patients of the Austrian psoriasis registry from 2004-2022Thomas Graier, Wolfgang Salmhofer, Constanze Jonak, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|December 12, 2023
Entwicklung der Patientencharakteristika und der Wirksamkeit der Biologika-Therapie bei Patienten des Österreichischen Psoriasis-Registers von 2004 bis 2022Thomas Graier, Wolfgang Salmhofer, Constanze Jonak, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 25, 2023
S2k guidelines on the management of paraneoplastic pemphigus/paraneoplastic autoimmune multiorgan syndrome initiated by the European Academy of Dermatology and Venereology (EADV)Emiliano Antiga, Rikke Bech, Roberto Maglie, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 13, 2023
Corrigendum: S2k guidelines on the management of paraneoplastic pemphigus/paraneoplastic autoimmune multiorgan syndrome initiated by the European Academy of Dermatology and Venereology (EADV)Emiliano Antiga, Rikke Bech, Roberto Maglie, et al.
Pageof 6